Starpharma Holdings Limited (ASX:SPL – Get Free Report) insider Russell Basser acquired 200,000 shares of Starpharma stock in a transaction dated Friday, September 13th. The stock was purchased at an average cost of A$0.09 ($0.06) per share, for a total transaction of A$18,600.00 ($12,567.57).
Starpharma Price Performance
The company has a current ratio of 4.94, a quick ratio of 5.65 and a debt-to-equity ratio of 12.55.
About Starpharma
Recommended Stories
- Five stocks we like better than Starpharma
- What Are Dividend Contenders? Investing in Dividend Contenders
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- What is a Death Cross in Stocks?
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
- Stock Market Sectors: What Are They and How Many Are There?
- What Buybacks and Lower Rates Could Mean for Restaurant Brands
Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.